If GLP1 is so great, why don't people stick with it?
Why are so few people able to stay on GLP1s for 3 years? We dig into the analysis & report by Prime Therapeutics.
Covering the benefits of GLP1s is great, covering new/novel negative side effects is even better, but finding out that one of the biggest problems with GLP1s is that people can't stick with them is quite the surprise.
Accessibility of GLP1s has reduced drastically this year with the phasing out of mass compounding, but prices have reduced from the $1000 MSRP that was quite common place in the past.
Recently some new research has shed light on yet another problem stopping GLP1s from revolutionizing weight management – they're hard to stick with over years.
